Concord Neonatal, one of the ventures in NLC portfolio, has closed a new funding round, securing substantial funding with private investors. Concord Neonatal is improving birth, by offering solutions to give baby’s a shock-free birth. This new funding allows the company to expand sales internationally and continue to scale-up.
Recent news
INTRODUCING BIODGRAFT: A SOLUTION FOR LIFE
PRESS RELEASE September 27, 2022 BioDGraft, an NLC venture, sets out to eliminate the need for vein harvesting in bypass surgeries, proposing a solution…
Read more
INTRODUCING AIDO: BUILDING THE FUTURE PLATFORM FOR INTERVENTIONAL ENDOSCOPY
PRESS RELEASE September 8, 2022 AIDO, an NLC venture, has made it its mission to bring more control to physicians performing endoscopic procedures and…
Read more
NLC Collaborates with FFUND and ttopstart to accelerate growth of healthtech ventures
PRESS RELEASE AUGUST 22, 2022 NLC – The European Healthtech Venture Builder, FFUND and ttopstart partner to accelerate the growth of life-saving healthcare ventures…
Read more